VistaGen Therapeutics's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
VistaGen Therapeutics last closed at $0.2462 (-0.36%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -0.2×. Its overall grade ranks 584 of 738 stocks in Healthcare.
About this company
VistaGen Therapeutics last closed at $0.2462 (-0.36%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C · 584/738
Valuation grade C
Related stocks
- AbbVieCustomer
주요 파이프라인 협력·사업화 가능성이 있는 대형 제약사
- AstraZenecaCompetitor
중추신경계·정신질환 치료제 개발 영역에서 경쟁 가능성이 있는 글로벌 제약사
- Johnson & JohnsonCompetitor
우울증·정신과 치료 포함 대형 CNS 신약 시장에서 경쟁하는 글로벌 제약사
About VistaGen Therapeutics
- What technical signals does VistaGen Therapeutics (VTGN) have?
- VistaGen Therapeutics current technical signals: no active technical signal.
- Is VistaGen Therapeutics a cup-and-handle pattern?
- No. VistaGen Therapeutics has no valid Cup signal right now.
- What published figures are available for VistaGen Therapeutics?
- Market cap: $9.72M. Trailing 12 months PER: -0.2×. Latest quarter PBR: 0.43×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about VistaGen Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.